Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of New Drug Modeling Solution
1.2 Key Market Segments
1.2.1 New Drug Modeling Solution Segment by Type
1.2.2 New Drug Modeling Solution Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 New Drug Modeling Solution Market Overview
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 New Drug Modeling Solution Market Competitive Landscape
3.1 Global New Drug Modeling Solution Revenue Market Share by Company (2019-2024)
3.2 New Drug Modeling Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company New Drug Modeling Solution Market Size Sites, Area Served, Product Type
3.4 New Drug Modeling Solution Market Competitive Situation and Trends
3.4.1 New Drug Modeling Solution Market Concentration Rate
3.4.2 Global 5 and 10 Largest New Drug Modeling Solution Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 New Drug Modeling Solution Value Chain Analysis
4.1 New Drug Modeling Solution Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 The Development and Dynamics of New Drug Modeling Solution Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 New Drug Modeling Solution Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global New Drug Modeling Solution Market Size Market Share by Type (2019-2024)
6.3 Global New Drug Modeling Solution Market Size Growth Rate by Type (2019-2024)
7 New Drug Modeling Solution Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global New Drug Modeling Solution Market Size (M USD) by Application (2019-2024)
7.3 Global New Drug Modeling Solution Market Size Growth Rate by Application (2019-2024)
8 New Drug Modeling Solution Market Segmentation by Region
8.1 Global New Drug Modeling Solution Market Size by Region
8.1.1 Global New Drug Modeling Solution Market Size by Region
8.1.2 Global New Drug Modeling Solution Market Size Market Share by Region
8.2 North America
8.2.1 North America New Drug Modeling Solution Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe New Drug Modeling Solution Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific New Drug Modeling Solution Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America New Drug Modeling Solution Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa New Drug Modeling Solution Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 JSR Corporation(Crown Bioscience)
9.1.1 JSR Corporation(Crown Bioscience) New Drug Modeling Solution Basic Information
9.1.2 JSR Corporation(Crown Bioscience) New Drug Modeling Solution Product Overview
9.1.3 JSR Corporation(Crown Bioscience) New Drug Modeling Solution Product Market Performance
9.1.4 JSR Corporation(Crown Bioscience) New Drug Modeling Solution SWOT Analysis
9.1.5 JSR Corporation(Crown Bioscience) Business Overview
9.1.6 JSR Corporation(Crown Bioscience) Recent Developments
9.2 Chemical Computing Group ULC
9.2.1 Chemical Computing Group ULC New Drug Modeling Solution Basic Information
9.2.2 Chemical Computing Group ULC New Drug Modeling Solution Product Overview
9.2.3 Chemical Computing Group ULC New Drug Modeling Solution Product Market Performance
9.2.4 JSR Corporation(Crown Bioscience) New Drug Modeling Solution SWOT Analysis
9.2.5 Chemical Computing Group ULC Business Overview
9.2.6 Chemical Computing Group ULC Recent Developments
9.3 Nimbus Therapeutics
9.3.1 Nimbus Therapeutics New Drug Modeling Solution Basic Information
9.3.2 Nimbus Therapeutics New Drug Modeling Solution Product Overview
9.3.3 Nimbus Therapeutics New Drug Modeling Solution Product Market Performance
9.3.4 JSR Corporation(Crown Bioscience) New Drug Modeling Solution SWOT Analysis
9.3.5 Nimbus Therapeutics Business Overview
9.3.6 Nimbus Therapeutics Recent Developments
9.4 schrodinger, Inc
9.4.1 schrodinger, Inc New Drug Modeling Solution Basic Information
9.4.2 schrodinger, Inc New Drug Modeling Solution Product Overview
9.4.3 schrodinger, Inc New Drug Modeling Solution Product Market Performance
9.4.4 schrodinger, Inc Business Overview
9.4.5 schrodinger, Inc Recent Developments
9.5 Genedata AG
9.5.1 Genedata AG New Drug Modeling Solution Basic Information
9.5.2 Genedata AG New Drug Modeling Solution Product Overview
9.5.3 Genedata AG New Drug Modeling Solution Product Market Performance
9.5.4 Genedata AG Business Overview
9.5.5 Genedata AG Recent Developments
9.6 Biognos AB
9.6.1 Biognos AB New Drug Modeling Solution Basic Information
9.6.2 Biognos AB New Drug Modeling Solution Product Overview
9.6.3 Biognos AB New Drug Modeling Solution Product Market Performance
9.6.4 Biognos AB Business Overview
9.6.5 Biognos AB Recent Developments
9.7 Compugen Ltd
9.7.1 Compugen Ltd New Drug Modeling Solution Basic Information
9.7.2 Compugen Ltd New Drug Modeling Solution Product Overview
9.7.3 Compugen Ltd New Drug Modeling Solution Product Market Performance
9.7.4 Compugen Ltd Business Overview
9.7.5 Compugen Ltd Recent Developments
9.8 Dassault Systemes
9.8.1 Dassault Systemes New Drug Modeling Solution Basic Information
9.8.2 Dassault Systemes New Drug Modeling Solution Product Overview
9.8.3 Dassault Systemes New Drug Modeling Solution Product Market Performance
9.8.4 Dassault Systemes Business Overview
9.8.5 Dassault Systemes Recent Developments
9.9 Acellera
9.9.1 Acellera New Drug Modeling Solution Basic Information
9.9.2 Acellera New Drug Modeling Solution Product Overview
9.9.3 Acellera New Drug Modeling Solution Product Market Performance
9.9.4 Acellera Business Overview
9.9.5 Acellera Recent Developments
9.10 lnstem(Leadscope)
9.10.1 lnstem(Leadscope) New Drug Modeling Solution Basic Information
9.10.2 lnstem(Leadscope) New Drug Modeling Solution Product Overview
9.10.3 lnstem(Leadscope) New Drug Modeling Solution Product Market Performance
9.10.4 lnstem(Leadscope) Business Overview
9.10.5 lnstem(Leadscope) Recent Developments
10 New Drug Modeling Solution Regional Market Forecast
10.1 Global New Drug Modeling Solution Market Size Forecast
10.2 Global New Drug Modeling Solution Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe New Drug Modeling Solution Market Size Forecast by Country
10.2.3 Asia Pacific New Drug Modeling Solution Market Size Forecast by Region
10.2.4 South America New Drug Modeling Solution Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of New Drug Modeling Solution by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global New Drug Modeling Solution Market Forecast by Type (2025-2030)
11.2 Global New Drug Modeling Solution Market Forecast by Application (2025-2030)
12 Conclusion and Key Findings
